logo

For the Inventor, By the Inventor

Gurnee, IL, United States of America

Ronald E Carney

USPTO Granted Patents = 15


Average Co-Inventor Count = 2.3

ph-index = 3

Forward Citations = 41(Granted Patents)


Location History:

  • Gurnee, IL (US) (1980 - 1983)
  • Winthrop Harbor, IL (US) (2000)

Company Filing History:

goldMedal15 out of 4,179 
 
Abbott Laboratories Corporation
 patents

Years Active: 1980-2000

Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents
1. 6080844 - Process for the recovery and purification of a recombinant protein from (2000-06-27),
2. 4423210 - Intermediates for the preparation of 3-demethoxyfortimicins (1983-12-27),
3. 4418193 - Method of producing 2-epi-fortimicin A (1983-11-29),
4. 4282211 - 1-Epi-2-deoxyfortimicin B and derivatives (1981-08-04),
5. 4272626 - Method of producing 1-epi-2-deoxyfortimicin A and intermediates therefor (1981-06-09),
6. 4239752 - O-Demethylseldomycin factor 5 derivatives (1980-12-16),
7. 4218442 - 1-Epi-fortimicin A and derivatives (1980-08-19),
8. 4218441 - O-Demethylseldomycin factor 5 (1980-08-19),
9. 4216210 - Fortimicins AM and AP derivatives (1980-08-05),
10. 4214080 - Fortimicins AM and AP (1980-07-22),
11. 4214077 - 1-N-Substituted derivatives of seldomycin factor 5 (1980-07-22),
12. 4208407 - 5-Deoxyfortimicin A, 2,5-dideoxyfortimicin A and the corresponding (1980-06-17),
13. 4207415 - Method of producing 2-deoxyfortimicin A (1980-06-10),
14. 4189569 - Seldomycin factor 5 derivatives (1980-02-19),
15. 4187372 - Seldomycin factor 5 derivative (1980-02-05),

Title: **Ronald E. Carney: Innovator in Protein Recovery and Pharmaceutical Development**

Introduction

Ronald E. Carney, based in Gurnee, IL, is a notable inventor with a remarkable portfolio comprising 15 patents. His impactful contributions primarily focus on the fields of biochemistry and pharmaceuticals, showcasing innovative processes that advance protein purification and drug development.

Latest Patents

Among Ronald's significant inventions, two of his latest patents stand out. The first, titled "Process for the recovery and purification of a recombinant protein from a suspension of cells," presents a refined method for extracting and purifying recombinant proteins. This process utilizes a water-miscible organic solvent to isolate the protein, subsequently concentrating and precipitating it for enhanced recovery.

The second patent, "Intermediates for the preparation of 3-demethoxyfortimicins," outlines the structure and preparation of fortimicin derivatives. These compounds serve as valuable intermediates in developing pharmaceuticals, emphasizing Ronald's role in aiding therapeutic advancements.

Career Highlights

Ronald E. Carney has played a pivotal role at Abbott Laboratories Corporation, where he has leveraged his expertise to innovate new methods and compounds within the pharmaceutical realm. His work has not only led to numerous patents but also created pathways for new treatments that can improve patient outcomes.

Collaborations

Throughout his career, Ronald has collaborated with esteemed colleagues such as James B. McAlpine and Jerry R. Martin. These partnerships have allowed for a rich exchange of ideas and expertise, contributing to the success of various projects and patents in which Ronald has been involved.

Conclusion

Ronald E. Carney exemplifies the spirit of innovation, with his extensive patent portfolio and significant contributions to biochemistry and pharmaceuticals. His work continues to influence the industry, paving the way for future breakthroughs in protein recovery and drug development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…